Measles-containing-vaccine second-dose (MCV2) … MCV2, WUENIC in Guinea
Guinea: Measles-containing-vaccine second-dose (MCV2) immunization coverage was 47.0% in 2025. ◆ Volatile
Measles-containing-vaccine second-dose (MCV2) immunization coverage in Guinea, 2000–2025
Source: World Health Organization, Global Health Observatory.
Analysis
Guinea recorded 47.0% for measles-containing-vaccine second-dose (mcv2) immunization coverage in 2025. That is the highest value across all 26 years on record.
That represents a change of up 4.4% on the previous year.
Over the whole period, measles-containing-vaccine second-dose (mcv2) immunization coverage in Guinea peaked at 47.0% in 2025 and was at its lowest, 0.0%, in 2000.
That places Guinea 177th out of 194 countries with data for 2025, putting it in the bottom quarter.
The series is highly variable year to year, so single readings are best treated with caution.
Measles-containing-vaccine second-dose (MCV2) immunization coverage in Guinea, year by year
| Year | Value | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 0.0% | — |
| 2004 | 0.0% | — |
| 2005 | 0.0% | — |
| 2006 | 0.0% | — |
| 2007 | 0.0% | — |
| 2008 | 0.0% | — |
| 2009 | 0.0% | — |
| 2010 | 0.0% | — |
| 2011 | 0.0% | — |
| 2012 | 0.0% | — |
| 2013 | 0.0% | — |
| 2014 | 0.0% | — |
| 2015 | 0.0% | — |
| 2016 | 0.0% | — |
| 2017 | 0.0% | — |
| 2018 | 0.0% | — |
| 2019 | 0.0% | — |
| 2020 | 0.0% | — |
| 2021 | 0.0% | — |
| 2022 | 3.0% | — |
| 2023 | 26.0% | +766.7% |
| 2024 | 45.0% | +73.1% |
| 2025 | 47.0% | +4.4% |
Guinea compared with similar countries
- Guinea's 47.0% is below the median for lower middle income countries, which is 70.0%, 67% of the median. (47 countries reporting)
- Guinea's 47.0% is below the median for Sub-Saharan Africa, which is 66.0%, 71% of the median. (48 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | 10 |
| 2010s | 0.0% | 0.0% | 0.0% | 10 |
| 2020s | 20.2% | 0.0% | 47.0% | 6 |
Countries ranked near Guinea
More health data for Guinea
- Un projection of annual infant deaths, annual growth rate -1.65 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.8529 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,123 deaths per 1,000 people (2090)
- Number of infants who die before age 1 11,190 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 113 (2025)
- Population ages 00-04, female, annual growth rate 0.9852 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0731 units per person (2025)
- Population ages 00-04, male, annual growth rate 0.9785 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is measles-containing-vaccine second-dose (mcv2) immunization coverage in Guinea?
- Measles-containing-vaccine second-dose (mcv2) immunization coverage in Guinea was 47.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest measles-containing-vaccine second-dose (mcv2) immunization coverage recorded in Guinea?
- The highest recorded value was 47.0% in 2025.
- What is the lowest measles-containing-vaccine second-dose (mcv2) immunization coverage recorded in Guinea?
- The lowest recorded value was 0.0% in 2000.
- How does Guinea rank for measles-containing-vaccine second-dose (mcv2) immunization coverage?
- Guinea ranks 177th out of 194 countries with data for 2025.
- Where does this Guinea data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Measles-containing-vaccine second-dose (MCV2) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 26 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).